Accordingly, Luo et al. performed the first study to examine STING expression in livers from patients with NAFLD and demonstrated a significant increase in STING expression in liver non-parenchymal cells (NPCs) relative to that in livers from subjects without NAFLD (9). This evidence concerns the gene STING1 and metabolic dysfunction-associated steatotic liver disease.